Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N01BB54	EMLA	B	Prilocaine - 25mg/g, Lidocaine - 25mg/g	5%	Cream	1,763,121 L.L
D06AX01	ACIDE FUSIDIQUE BGR	G	Fusidic acid - 2%	2%	Cream	202,920 L.L
N01BB54	PRILA	G	Prilocaine - 2.5% w/w, Lidocaine - 2.5% w/w		Cream	1,057,604 L.L
D06AX01	DERMICIN	G	Fusidic acid - 20mg/g	20mg/g	Cream	175,339 L.L
D06AX01	DERMOFUCIN	G	Fusidic acid - 2%	2%	Cream	290,270 L.L
D06AX01	FUTASOLE	G	Fusidic acid - 20mg/g	2%	Cream	145,135 L.L
D06AX01	ZETA	G	Fusidic acid - 20mg/g	20mg/g	Cream	178,731 L.L
D06BA01	SILVEDERMA	G	Silver sulfadiazine - 1%	10mg/g	Cream	1,220,209 L.L
D06BA01	SILVEDERMA	G	Silver sulfadiazine - 1%	10mg/g	Cream	494,534 L.L
D06BA02	CREM-O-SULFA	G	Sulfathiazole - 5%	5%	Cream	202,216 L.L
D06BA51	IALUGEN PLUS	B	Silver sulfadiazine - 10mg/g, Sodium hyaluronate - 2mg/g		Cream	1,064,323 L.L
D06BA51	HYALO4 PLUS	G	Hyaluronic acid (sodium) - 0.2%, Silver sulfadiazine - 1%		Cream	466,313 L.L
D06BA51	SILVEZ PLUS	G	Silver sulfadiazine - , Chlorhexidine -		Cream	349,399 L.L
D06BB03	CIVAR	G	Aciclovir - 5%	5%	Cream	507,972 L.L
D06BB03	CYCLOVEX	G	Aciclovir - 50mg/g	50mg/g	Cream	267,489 L.L
D06BB10	ALDARA	B	Imiquimod - 5%	5%	Cream	6,301,277 L.L
D06BB10	GENIMOD	G	Imiquimod - 5%	5%	Cream	2,268,406 L.L
D06BB10	JEDARA	G	Imiquimod - 5%	5%	Cream	3,850,109 L.L
D06BB53	ACTI-VIR H	G	Aciclovir - 5%, Hydrocortisone acetate - 1%		Cream	833,182 L.L
D07AA02	HYDROCORTISONE ACETATE	G	Hydrocortisone acetate - 1%	1%	Cream	215,015 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.1%	Cream	215,015 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.1%	Cream	215,015 L.L
D07AC01	BETNOVATE	B	Betamethasone (valerate) - 0.1%	0.1% w/w	Cream	279,519 L.L
D07AC01	BETASONE	G	Betamethasone (valerate) - 1mg/g	1mg/g	Cream	120,306 L.L
D07AC01	DIPROSONE	B	Betamethasone (dipropionate) - 0.5mg/g	0.05%	Cream	291,614 L.L
D07AC04	FLUOCINOLONE ACETONIDE	G	Fluocinolone acetonide - 0.25mg/g	0.25mg/g	Cream	296,925 L.L
D07AC13	ELICA	G	Mometasone furoate - 1mg/g	0.1%	Cream	341,336 L.L
D07AC13	ELISONE	G	Mometasone furoate - 0.1%	0.1%	Cream	249,955 L.L
D07AC13	ELISONE	G	Mometasone furoate - 0.1%	0.1%	Cream	435,405 L.L
D07AC13	METASONE	G	Mometasone furoate - 0.1%	0.1%	Cream	335,321 L.L